RSS-Feed abonnieren
DOI: 10.1055/s-2003-41487
Concise Synthesis of Optically Pure syn-1,3-Diols by Stereoselective Desymmetrization of a Divinylcarbinol
Publikationsverlauf
Publikationsdatum:
19. September 2003 (online)

Abstract
Divinylcarbinols 17 and 18, CS-symmetrical and cis-configured, were desymmetrized by Sharpless’ asymmetric epoxidation. This furnished anti-configured monoepoxy alcohols 19 (85% ee) and 20 (94% ee), respectively, or their mirror images (ent-19, 84% ee; ent-20, 95% ee). 20 (ent-20) was reduced by Red-Al® regio- and chemoselectively, providing syn-1,3-diols ent-21 (21) at low and ent-22 (22) at higher temperature (94-95% ee). They should allow the obtention of more elaborated syn-1,3-diols.
Key words
acetonides - desymmetrization - 1,3-diols - epoxyalcohols - Sharpless asymmetric epoxidation
- For leading references on asymmetric desymmetrizations of substrates containing no stereocenter, see:
-
1a
Tamao K.Tohma T.Inui N.Nakayama O.Ito Y. Tetrahedron Lett. 1990, 31: 7333 -
1b
Shibasaki M.Boden CDJ.Kojima A. Tetrahedron 1997, 53: 7371 -
1c
Angelaud R.Babot O.Charvat T.Landais Y. J. Org. Chem. 1999, 64: 9613 -
1d
Bahmanyar S.Houk KN. J. Am. Chem. Soc. 2001, 123: 11273 -
1e
Evans PA.Cui J.Buffone GP. Angew. Chem. Int. Ed. 2003, 42: 1734 ; Angew. Chem. 2003, 115, 1776 - For leading references on asymmetric desymmetrizations of substrates, which are meso-configured, see:
-
2a
Hodgson DM.Gibbs AR.Lee GP. Tetrahedron 1996, 52: 14361 -
2b
La DS.Alexander JB.Cefalo DR.Graf DD.Hoveyda AH.Schrock RR. J. Am. Chem. Soc. 1998, 120: 9720 -
2c
Jacobsen EN. Acc. Chem. Res. 2000, 33: 421 -
2d
BouzBouz S.Cossy J. Org. Lett. 2001, 3: 3995 -
2e
Katsuki T. Curr. Org. Chem. 2001, 5: 663 -
2f
Harada T.Egusa T.Igarashi Y.Kinugasa M.Oku A. J. Org. Chem. 2002, 67: 7080 -
2g
Vares L.Rein T. J. Org. Chem. 2002, 67: 7226 -
3a
Schreiber SL. Chem. Scr. 1987, 27: 563 -
3b
Ward RS. Chem. Soc. Rev. 1990, 19: 1 -
3c
Poss CS.Schreiber SL. Acc. Chem. Res. 1994, 27: 9 -
3d
Maier M. In Organic Synthesis Highlights IIWaldmann H. VCH; Weinheim New York: 1995. p.203 -
3e
Magnuson SR. Tetrahedron 1995, 51: 2167 -
3f
Willis MC. J. Chem. Soc., Perkin Trans. 1 1999, 1765 -
3g
Hoffmann RW. Angew. Chem. Int. Ed. 2003, 42: 1096 ; Angew. Chem. 2003, 115, 1128 -
4a
Katsuki T.Sharpless KB. J. Am. Chem. Soc. 1980, 102: 5976 -
4b
Gao Y.Hanson RM.Klunder JM.Ko SY.Masamune H.Sharpless KB. J. Am. Chem. Soc. 1987, 109: 5765 -
5a
Hatakeyama S.Sakurai K.Takano S. J. Chem. Soc., Chem. Commun. 1985, 1759 -
5b
Häfele B.Schröter D.Jäger V. Angew. Chem. Int. Ed. Engl. 1986, 25: 87 ; Angew. Chem. 1986, 98, 89 -
5c
Schreiber SL.Schreiber TS.Smith DB. J. Am. Chem. Soc. 1987, 109: 1525 -
5d
Smith DB.Wang Z.Schreiber SL. Tetrahedron 1990, 46: 4793 -
5e
Nakatsuka M.Ragan JA.Sammakia T.Smith DB.Uehling DE.Schreiber SL. J. Am. Chem. Soc. 1990, 112: 5583 -
5f
Jäger V.Hümmer W.Stahl U.Gracza T. Synthesis 1991, 769 - 6
Hatakeyama S.Sakurai K.Numata H.Ochi N.Takano S. J. Am. Chem. Soc. 1988, 110: 5201 -
7a
Herunsalee A.Isobe M.Pikul S.Goto T. Synlett 1991, 199 -
7b
Hatakeyama S.Satoh K.Takano S. Tetrahedron Lett. 1993, 34: 7425 -
7c
Esumi T.Fukuyama H.Oribe R.Kawazoe K.Iwabuchi Y.Irie H.Hatakeyama S. Tetrahedron Lett. 1997, 38: 4823 -
7d
Nishioka T.Iwabuchi Y.Irie H.Hatakeyama S. Tetrahedron Lett. 1998, 39: 5597 -
8a
Omura S.Tanaka H. In Macrolide Antibiotics: Chemistry, Biology and PracticeOmura S. Academic Press; New York: 1984. p.351-404 -
8b
Oishi T.Nakata T. Synthesis 1990, 635 -
8c
Rychnovsky SD. Chem. Rev. 1995, 95: 2021 -
8d
Schneider C. Angew. Chem. Int. Ed. 1998, 37: 1375 ; Angew. Chem. 1998, 110, 1445 -
11a
Rieke RD.Uhm SJ.Hudnall PM. J. Chem. Soc., Chem. Commun. 1973, 269 -
11b
Rieke RD.Uhm SJ. Synthesis 1975, 452 - Procedure:
-
12a
Avignon-Tropis M.Pougny JR. Tetrahedron Lett. 1989, 30: 4951 -
12b
Chou W.-N.Clark DL.White JB. Tetrahedron Lett. 1991, 32: 299 -
13a
Johnson RA.Sharpless KB. In Catalytic Asymmetric SynthesisOjima IE. Wiley-VCH; New York: 1993. p.103-158 -
13b
Katsuki T.Martin VS. Org. React. 1996, 48: 1 - SAEs of cis-2-butene-1,4-diol mono-protected with a tert-butyldimethylsilyl roup:
-
14a
Astles PC.Thomas EJ. J. Chem. Soc., Perkin Trans. 1 1997, 845; 85% ee -
14b
Shibuya H.Kawashima K.Narita N.Ikeda M.Kitagawa I. Chem. Pharm. Bull. 1992, 40: 1154; 84-85% ee - SAEs of cis-2-butene-1,4-diol mono-protected with a PMB group:
-
15a
Williams RM.Rollins SB.Judd TC. Tetrahedron 2000, 56: 521; 88% ee -
15b
Yoshino T.Nagata Y.Itoh E.Hashimoto M.Katoh T.Terashima S. Tetrahedron 1997, 53: 10239; 85% ee - 17
Still WC.Kahn M.Mitra A. J. Org. Chem. 1978, 43: 2923 - 21 Moreover, tert-butyldimethylsiloxy groups do not withstand prolonged exposure to Red-Al®:
Berkenbusch T. PhD Dissertation Universität Freiburg; Germany: 2002. - Regioselective reductions of α,β-epoxy alcohols resulting in 1,3-diols (Red-Al®-method) or 1,2-diols (DIBAL-method):
-
23a
Finan JM.Kishi Y. Tetrahedron Lett. 1982, 23: 2719 -
23b
Viti SM. Tetrahedron Lett. 1982, 23: 4541 -
25a
Rychnovsky SD.Skalitzky DJ. Tetrahedron Lett. 1990, 31: 945 -
25b
Rychnovsky SD.Rogers B.Yang G. J. Org. Chem. 1993, 58: 3511 -
25c
Evans DA.Rieger DL.Gage JR. Tetrahedron Lett. 1990, 31: 7099 - 26 The asymmetric desymmetrization of a bicyclic, tertiary dialkenylcarbinol by the zirconium analog of a SAE, employing 3.0-3.4 equivalents each of Zr(i-PrO)4, d-(-)-diisopropyl tartrate, and t-BuOOH is described in:
Spivey AC.Woodhead SJ.Weston M.Andrews BI. Angew. Chem. Int. Ed. 2001, 40: 769 ; Angew. Chem. 2001, 113, 791
References
Compound 16 has been previously prepared, see ref. [7a]
10Except for compound 24, all new compounds gave satisfactory 1H NMR and IR spectra as well as correct combustion analyses.
16This was concluded from the integral ratio of the peaks attributed to 3-H [δmajor = 3.02 (dd; 19/ent-19), δminor = 3.08(dd)].
18In addition, we retrieved inseparable mixtures of mono- with bis-epoxides.
19This was concluded from the integral ratio of the peaks attributed to 3-H [δmajor = 3.00 (dd; 20/ent-20), δminor = 3.06(dd)].
20
cis-(2R,3S,4S)-2,3-Epoxy-1,7-bis-[4-methoxybenzyl)oxy]-5-hepten-4-ol(20): [α]D
25 = -30.9 (c = 0.58 in CHCl3);
- 94.4% ee by HPLC.
1H NMR (500.0 MHz, CDCl3): δ = 2.80 (d, J
OH,4 = 2.3 Hz, OH), 3.00 (dd, J
3,4 = 7.5 Hz, J
3,2 = 4.3 Hz, 3-H), 3.25 (mc, probably incompletely resolved ddd: J
2,1-H(A) = J
2,1-H(B) =
ca. 5.7 Hz, J
2,3 = 4.3 Hz, 2-H), AB signal (δA = 3.63, δB = 3.79, J
AB = 11.1 Hz, in addition split by J
A,2 = 6.2 Hz, J
B,2 = 5.4 Hz, 1-H2), B part superimposed by 3.80 (s, 2 × OCH3), AB signal (δA = 4.05, δB = 4.11, J
AB = 12.9 Hz, in addition split by J
A,6 = 5.7 Hz, 4
J
A,5-H = 1.4 Hz, J
B,6 = 6.7 Hz, 4
J
B,5-H = 1.5 Hz, 7-H2), 4.25 (br dd, J
4,3 = J
4,5 = 7.5 Hz, 4-H), 4.42
(s, 1′′-H2)*, AB signal (δA = 4.46, δB = 4.54, J
AB = 11.4 Hz,
1′-H2), 5.70 (dddd, J
cis
= 11.3 Hz, J
5,4 = 7.6 Hz, 4
J
5,7-H(A) = 4
J
5,7-H(B) = 1.5 Hz, 5-H), 5.82 (br ddd, J
cis
= 11.4 Hz,
J
6,7-H(A) = J
6,7-H(B) = 6.0 Hz, 6-H), AA′BB′ signal centered at δ = 6.88 and δ = 7.26 (2 × C6H4).
13C NMR (125.8 MHz, CDCl3): δ = 54.73 (C-2), 55.26 (2 × OCH3), 58.12 (C-3), 65.80 (C-7), 66.34 (C-4), 68.00 (C-1), 72.02 (C-1′′), 73.20 (C-1′), 113.83, 113.96, 129.46, and 129.60 (2 × 2 × C
ortho
, 2 × 2 × C
meta
), 129.32, 130.03, 159.28, and 159.51 (2 × C
para
, 2 × C
ipso
), 130.29 (C-6), 131.71 (C-5).
IR(film): 3400, 3000, 2935, 2910, 2860, 2835, 1610, 1585, 1515, 1460, 1300, 1250, 1175, 1075, 1035, 850, 820 cm-1.
Anal. Calcd for C23H28O6 (400.5): C, 68.98; H, 7.05. Found C, 68.99; H, 7.20.
cis-(2S,4R)-1,7-Bis-[(4-methoxybenzyl)oxy]-5-heptene-2,4-diol (ent-21): [α]D
25 = 14.8 (c = 0.78 in CHCl3).
1H NMR (500.0 MHz, CDCl3): δ = AB signal (δA = 1.55,
δB = 1.71, J
AB = 14.2 Hz, in addition split by J
A,4 = 4.4 Hz, J
A,2 = 2.7 Hz, J
B,2 = 9.9 Hz, J
B,4 = 8.8 Hz, 3-H2), 3.07 (br s, 2 × OH), AB signal (δA = 3.35, δB = 3.40, J
AB = 9.5 Hz, in addition split by J
A,2 = 7.1 Hz, J
B,2 = 4.1 Hz, 1-H2), 3.795 and 3.804 (2 × s, 2 × OCH3), 3.96 (mc, 2-H), AB signal (δA = 4.06, δB = 4.09, J
AB = 12.4 Hz, in addition split by J
A,6 = 6.1 Hz, 4
J
A,5-H = 1.3 Hz, J
B,6 = 6.4 Hz, J
B,5-H = 1.3 Hz, 7-H2), AB signal (δA = 4.43, δB = 4.46, J
AB = 11.2 Hz, 1′-H2), B part partly superimposed by 4.47 (s, 1′′-H2), 4.67 (ddd with incompletely resolved allylic couplings, J
4,5 = J
4,3-H(B) = 8.4 Hz, J
4,3-H(A) = 4.2 Hz, 4-H), 5.60 (dddd, J
cis
= 11.4 Hz, J
5,4 = 8.0 Hz, 4
J
5,7-H(A) = 4
J
5,7-H(B) = 1.3 Hz, 5-H), 5.68 (dddd, J
cis
= 11.2 Hz, J
6,7-H(A) = J
6,7-H(B) = 6.2 Hz, 4
J
6,4 = 0.9 Hz, 6-H), AA′BB′ signal centered at δ = 6.87 and δ = 7.25 (2 × C6H4).
13C NMR (125.7 MHz, CDCl3): δ = 39.74 (C-3), 55.26 (2 × OCH3), 65.54, 67.63, 70.20, 72.19, 73.06 and 74.00 (C-1, C-2, C-4, C-7, C-1′, C-1′′), 113.85, 127.69, 129.40, 129.50, 129.93, 129.97, 135.72, 159.32, and 159.33 (9 resonances for 10 non-equivalent nuclei: C-5, C-6, 2 × C6H4).
IR(film): 3400, 3000, 2920, 2855, 1615, 1585, 1515, 1465, 1455, 1445, 1420, 1360, 1300, 1245, 1175, 1075, 1030, 820 cm-1.
Anal. Calcd for C23H30O6 (402.5): C, 68.64; H, 7.51. Found: C, 68.34; H, 7.24.
(2R,4R)-1-[(4-Methoxybenzyl)oxy]-6-heptene-2,4-diol (22): [α]D
25 = -1.9 (c = 0.81 in CHCl3).
1H NMR (500.0 MHz, CDCl3): δ = AB signal (δA = 1.53,
δB = 1.62, J
AB = 14.4 Hz, in addition split by J
A,2 = J
A,4 = 9.8 Hz, J
B,2 = J
B,4 = 2.7 Hz, 3-H2), 2.25 (dddd, J
5,6 = 7.3 Hz, J
5,4 = 6.2 Hz, 4
J
5,7-H(E) = 4
J
5,7-H(Z) = 1.1 Hz, 5-H2), 2.91-3.28 (m, 2 × OH), AB signal (δA = 3.35, δB = 3.43, J
AB = 9.4 Hz, in addition split by J
A,2 = 7.1 Hz, J
B,2 = 3.9 Hz, 1-H2), 3.81 (s, OCH3), 3.92 (dtd with transition to higher order splitting, J
4,3-H(A) = 9.8 Hz, J
4,5 = 6.1 Hz, J
4,3-H(B) = 2.5 Hz, 4-H), 4.04 (dddd, J
2,3-H(A) = 10.4 Hz, J
2,1-H(A) = 6.6 Hz, J
2,1-H(B) = 3.8 Hz, J
2,3-H(B) = 3.1 Hz, 2-H), 4.48 (s, 1′-H2), 5.09-5.14 (m, 7-H
E
, 7-H
Z
), 5.82 (mc, 6-H), AA′BB′ signal centered at δ = 6.88 and δ = 7.25 (C6H4).
13C NMR (125.7 MHz, CDCl3): δ = 38.71 and 42.21 (C-3, C-5), 55.26 (OCH3), 71.02, 71.16, 73.05, and 73.99 (C-1, C-2, C-4, C-1′), 113.86 and 129.41 (2 × C
ortho
, 2 × C
meta
), 117.86, 129.89, 134.51, and 159.35 (C-6, C-7, C
para
, C
ipso
).
IR(film): 3400, 3075, 2915, 2860, 1640, 1615, 1585, 1515, 1460, 1440, 1365, 1300, 1250, 1175, 1100, 1035, 990, 920, 820 cm-1.
Anal. Calcd for C15H22O4 (266.3): C, 67.64; H, 8.33. Found: C, 67.54; H, 8.39.